News

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...
Telehealth platform Hims & Hers said on Friday it will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S ...
An inexpensive pill for treating HIV could become an alternative to injections for diabetic eye disease, a small study ...
It's been a tough year for Novo Nordisk, the Danish pharmaceutical company behind the GLP-1 drugs Ozempic and Wegovy.
It's been a tough year for Novo Nordisk, the Danish pharmaceutical company ... For your first month of treatment, Reuters reports, you can nab a batch of Wegovy injections for $199 until June ...
Sure, I wee like Austin Powers and the number twos are like tennis balls – get comfortable with that idea. But I’m the best ...
US President Donald Trump has backed away from a threat to impose 50% tariffs imminently on imports from the European Union, ...
(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...
Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...
Whichever way the tariff winds blow (and I've no special knowledge of that), Novo Nordisk stock remains arguably the cheapest ...
Despite Lars Fruergaard Jørgensen's resignation as Novo Nordisk's CEO, its stock price has risen 10% over the past two weeks.